SEC Filing Details

Document Details

Form
Filing Date
Sep 05, 2024
Document Date
Sep 03, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.
Filer
HASSAN FRED